Commonwealth Bank of Australia’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-470
Closed -$59K 1073
2019
Q2
$59K Buy
470
+152
+48% +$19.1K ﹤0.01% 969
2019
Q1
$41K Hold
318
﹤0.01% 980
2018
Q4
$28K Buy
318
+17
+6% +$1.5K ﹤0.01% 1000
2018
Q3
$40K Buy
301
+100
+50% +$13.3K ﹤0.01% 1009
2018
Q2
$23K Buy
201
+80
+66% +$9.15K ﹤0.01% 731
2018
Q1
$12K Sell
121
-100
-45% -$9.92K ﹤0.01% 752
2017
Q4
$24K Sell
221
-4
-2% -$434 ﹤0.01% 696
2017
Q3
$30K Sell
225
-706
-76% -$94.1K ﹤0.01% 692
2017
Q2
$112K Sell
931
-38
-4% -$4.57K ﹤0.01% 685
2017
Q1
$118K Buy
969
+23
+2% +$2.8K ﹤0.01% 658
2016
Q4
$116K Buy
946
+46
+5% +$5.64K ﹤0.01% 620
2016
Q3
$111K Hold
900
﹤0.01% 618
2016
Q2
$105K Sell
900
-7
-0.8% -$817 ﹤0.01% 606
2016
Q1
$126K Buy
907
+183
+25% +$25.4K ﹤0.01% 613
2015
Q4
$137K Buy
724
+186
+35% +$35.2K ﹤0.01% 642
2015
Q3
$84K Buy
538
+109
+25% +$17K ﹤0.01% 673
2015
Q2
$77K Buy
429
+229
+115% +$41.1K ﹤0.01% 639
2015
Q1
$35K Sell
200
-100
-33% -$17.5K ﹤0.01% 736
2014
Q4
$56K Sell
300
-3,800
-93% -$709K ﹤0.01% 678
2014
Q3
$680K Sell
4,100
-100
-2% -$16.6K 0.01% 549
2014
Q2
$656K Sell
4,200
-12,578
-75% -$1.96M 0.01% 539
2014
Q1
$2.55M Buy
16,778
+3,500
+26% +$533K 0.02% 598
2013
Q4
$1.77M Buy
13,278
+1,578
+13% +$210K 0.01% 660
2013
Q3
$1.36M Hold
11,700
0.01% 672
2013
Q2
$1.08M Buy
+11,700
New +$1.08M 0.01% 713